ClinicalTrials.gg
Status unknownNCT02802956Updated Jun 16, 2016

A Preliminary Feasibility Efficacy of Participation in Daily Life Promotion Program

An interventional study of Daily Life Promotion Program and general rehabilitation treatment in Stroke, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 20 Years to 90 Years. Per ClinicalTrials.gov, last updated 2016-06-16.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jun 2016), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
20 Years to 90 Years
Sex
All
01

Study summary

Efficacy of Participation in Daily Life Promotion Program for Patients with Chronic Stroke

Read the detailed description

The purpose of this three-year research project is to develop an intervention program to promote participation in daily life for patients with chronic stroke and to evaluate its efficacy.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Life participation
03

In context

Stroke

7,441 studies on the registry are indexed under Stroke; 2,012 are open to participants now.

This study's planned enrollment of 30 is below the median of 50 across 5,482 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,608 studies on the registry; 573 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient with stroke after 6 months.
  • Must be able to follow orders and no other cognition impairment, Mini Mental State Examination scale must >20.

Exclusion criteria

Exclusion Criteria:

  • Clinical diagnosis of Dementia or Psychosis.
  • Clinical diagnosis of Musculoskeletal disorders or Nervous system diseases.
  • Patient with Congestive Heart Failure, Hypertension, Atrial fibrillation.
  • Could not communication with others.
  • Foreigner.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    intervention group

    Daily Life Promotion Program

    Other: Daily Life Promotion Program

  • Experimental
    control group

    general rehabilitation treatment

    Other: general rehabilitation treatment

Interventions

  • OtherDaily Life Promotion Program

    Daily Life Promotion Program

  • Othergeneral rehabilitation treatment

    general rehabilitation treatment

06

What researchers measure

Primary outcomes

  1. Stroke Impact Scale(SIS)

    quality of life measure

    Time frame: one year

Secondary outcomes

  1. Postural Assessment Scale for Stroke patients(PASS)

    motor performance measure

    Time frame: one year

  2. Action Research Arm Test(ARAT)

    motor performance measure

    Time frame: one year

  3. Fugl-Meyer Assessment(FMA)

    motor performance measure

    Time frame: one year

  4. self-rated abilities for health practice scale

    self-efficacy factors measure

    Time frame: one year

  5. WHO Quality of Life-BREF (Taiwan version)

    quality of life measure

    Time frame: one year

  6. Taiwan Instrumental Activities of Daily Living(TIADL)

    self-care ability measure

    Time frame: one year

  7. Barthel Index

    self-care ability measure

    Time frame: one year

07

Study locations

1 site
  • National Taiwan University Hospital
    Taipei, Test2 test3, Taiwan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2016, a primary completion of Dec 2018 and a completion of Dec 2018. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2016
First posted
Jun 16, 2016
Start
Jun 2016
Primary completionEst.
Dec 2018
CompletionEst.
Dec 2018
Last update
Jun 16, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 16, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02802956
Responsible party
Sponsor
First posted
Jun 16, 2016
Start date
Jun 2016
Primary completion
Dec 2018 (estimated)
Completion
Dec 2018 (estimated)
Last update
Jun 16, 2016

Study contacts

I MING HSIAO
Contact
skipbeat227@gmail.com
886-2-23123456*70420
Yi-Jiun Yang
Contact
skipbeat227@gmail.com
886-2-23123456*66763
I MING HSIAO
principal investigator · National Taiwan University Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion